The FreeMind Group is proud to support the upcoming Trans-Pacific Health Science Dialogue!

Where: Boston, MA

When: September 28-29, 2016

 

Big Players Are Making Big Bets on Biopharma in Asia

  • Chinese investors representing more than $5.5B are looking for Trans-Pacific investments
  • Pfizer is investing $150M in a biologics plant in China
  • BMS expects Opdivo sales in Japan to exceed $1B
  • The Hangzhou Economic Development Area is investing $350M in a global biotech center

Can You Afford to Sit on the Sidelines?

The time to think about establishing, expanding or accelerating an Asian strategy is now. With a lineup of top Asia experts, the Trans-Pacific Health Sciences Dialogue will provide you with a solid grasp of Asian biopharma opportunities and today’s best strategies for market entry and growth. This two-day event provides critical insights you will not find at any other meeting.

 

EARLY REGISRATION ENDS SOON >>> SAVE $300!

For complete details and to register go to:

www.TransPacificHSD.com

The FreeMind Group is a proud supporter of AdvaMed 2016

Where: Minneapolis, MN

When: October 17-19, 2016

 

AdvaMed 2016 is the leading MedTech Conference in North America, bringing more than 1,000 companies together for business development, capital formation, world-class educational opportunities and networking. A “must attend” event featuring a diverse attendee list that includes influential policy-makers, executives and media, AdvaMed 2016 seeks to advance the industry from key perspectives through panel sessions, executive forums and more.

Learn more about the event at www.advamed2016.com.

 

FreeMind is proud to support RESI Boston 2016 and invites you to use discount code FREEMIND100 for $100 off registration!

WhenTuesday, September 13, 2016

Where: The Westin Copley Place, Boston, MA

The first Redefining Early Stage Investments (RESI) Conference took place on September 16, 2013, and three years later, following highly successful events in San Francisco, Houston and Toronto, RESI will return to Boston for the 10th RESI Conference. Life Science Nation (LSN) will be hosting the RESI Boston conference in collaboration with Johnson & Johnson Innovation, JLABS on September 13th, 2016.
RESI Boston is a venue for entrepreneurs to meet with 10 categories of investors that LSN tracks including: Family Offices, Corporate Venture Funds, Angel Groups, Venture Philanthropy, Venture Capital and more. Through the RESI Partnering system, fundraising executives can have up to 16 scheduled meetings as well as many more ad-hoc meetings with diverse life science investors who fit their company’s technology sector, indication and stage of development.

 

Attend BioSpain 2016

Bilbao, Spain
September 28-30

The FreeMind Group is a Proud Supporter of Biospain 2016

BIOSPAIN 2016 is organized by ASEBIO, the Spanish Bioindustry Association and the Basque Government through the SPRI, the Basque Business Development Agency.

Biotech professionals from across Europe, America and Asia will converge on Biospain 2016 for a 3-day conference designed to explore innovation and biotech challenges. BIOSPAIN consists of a Trade Exhibition, an Investment Forum, a complete program of conferences and a partnering system provided by EBD Group’s partneringONE®.  Highlights from the program include workshops and conferenceslike CRISPR, Big Data, New models of Pharma Innovation through acquisition, Cross Borders Venture Capital Investments, VC Investment in Diagnostics & Medical Devices, Early Stage Investment, Cancer Immunotherapy, New Diagnostic Methods, Vaccines, Alzheimer, Food and Health, Public Policies to access Innovation, Bioeconomy, Nanobiotechnology, New Oncology Therapies, among others.

BIOSPAIN Investment Forum is an international event which allows international innovative biotechnology businesses to meet with an audience of leading biotech investors.
Companies seeking international finance or partners will have the opportunity to present their business project to an audience of top corporate funds, venture capital, business angels and crowd funding platforms.

The last edition: Biospain 2014
Following the success of previous editions, Biospain 2014 hosted 200 exhibitors, more than 850 companies and institutions and over 1.850 delegates from 37 countries. One-to-one business meetings rose to 3.327 (+20%) making Biospain one of the largest business & technology transfer partnering events in the world, ranked 5th in the year 2014.

June’s going to be a busy month and we’re heading to BIO International 2016 to kick it off right!

Set up a time via the partnering system or email Irina ([email protected]) to schedule a 1×1 meeting with:
* Ram May-Ron, Managing Partner
* Ayal Ronen, Vice President
* Inna Grodzovski, Senior Analyst
* Jonathan Adalist, Senior Director, Business Development
* Stuart Jacobowitz, Director, Business Development

Don’t forget to stop by the FreeMind Booth (#536) next to the Business Forum and enter to win a free Grant’s!

FreeMind is pleased to announce its sponsorship and invite you to attend New York Venture Summit presented by youngStartup Ventures.

**Special discount**  Use discount code “FREEMINDVIP” and receive 10% off the “Early Bird” rates!
New York Venture Summit

Where Innovation Meets Capital

July 20 & 21, 2016 | Crowne Plaza | New York City 

Friends,

Come meet, interact and network with more than 500 VCs, Corporate VCs, angel investors, investment bankers and CEOs of early stage and emerging growth companies at the prestigious New York Venture Summit being held on July 20th – 21st , 2016 at the Crowne Plaza in New York City.

Whether you’re a startup seeking capital and exposure, or an investor seeking new deals, The New York Venture Summit presented by youngStartup Ventures – is the event of the year you won’t want to miss.

A  highly productive venture conference, The New York Venture Summit is dedicated to showcasing VCs, Corporate VCs and angel investors committed to funding early stage and emerging companies.

This exclusive summit will feature a distinguished line up of more than 50 Investors on interactive panelspresentations by more than 50 cutting edge companies seeking funding, and high-level networking opportunities.

List of VC Speakers & Judges from 2015 Include:

  • Imraan Ahmed, Senior Associate, Radius Ventures
  • Logan Bartlett,Associate, Battery Ventures
  • Marty Bauer,Managing Director, Iron Yard Ventures
  • Gil Beyda,Founder & Managing Partner, Genacast Ventures
  • Greg Bohlen,Managing General Partner, Union Grove Venture Partners
  • Michael Boshammer,Managing Director, T-Venture
  • Todd Breeden,Vice President, StarVest Partners
  • Ari Brettman,Associate, Clarus Ventures
  • Stanley Buchesky,Partner and Founder, The EdTech Fund
  • Carter Caldwell,Principal, Cross Atlantic Capital Partners
  • Max Chee,Partner, Millennium Technology Ventures
  • Elizabeth Chou,Principal, New Markets Venture Partners
  • Daniel Chui,Manager, Verizon Ventures
  • Josh Cohen,Managing Partner & Co-founder, City Light Capital
  • Tom Costin,Principal, Owl Ventures
  • Randall Crowder,Managing Director, TEXO Ventures
  • Rajeev Dadoo,Partner, SR One
  • Sutian Dong ,Senior Associate, First Mark Capital
  • Jonathan Drillings,Principal, Comcast Ventures
  • Jim Dugan,CEO and Managing Partner, OCA Ventures
  • Eliot Durbin,General Partner, Boldstart Ventures
  • Imran Eba,Partner, Action Potential Venture Capital
  • Rami Elkhatib,General Partner, Acero Capital
  • Brad Farkas,Partner and Co-Founder, I-Hatch Ventures
  • Rita Ferrandino,Partner, Arc Capital Development
  • Allison Goldberg,Managing Director and Vice President, Time Warner Investments
  • Jay Goldberg,Senior Managing Director, Hudson Ventures
  • Daniel Goldman,Founder, President & CFO, Clean Energy Venture Group
  • Henrik Holland ,Venture Principal, Shell Technology Ventures
  • Sachin Jade,Partner, Klifer Capital
  • Douglas Jamison,Managing Director & CEO, Harris & Harris Group
  • Aaron Kantoff,Vice President, Apple Tree Partners
  • Joe King,Managing Director, DuPont Ventures
  • Roman Kikta,Managing Partner, Mobility Ventures
  • David Kirkpatrick,Managing Director, SJF Ventures
  • Jason Klein,Founder & CEO, OnGrid Ventures
  • Sarah Kunst,Venture Partner, Future Perfect Ventures
  • Sharon LaDay,Vice President, Macmillan New Ventures
  • Lisa Lambert,Managing Director, Intel Capital
  • Angela Lee,Founder & CEO, 37 Angels
  • Jennifer Lee,Principal, Learn Capital
  • Jenny Lefcourt ,Partner, Freestyle Capital
  • Ross Leimberg,Senior Manager, AbbVie Biotech Ventures
  • Jim Logerfo,Partner, Earthrise Capital
  • Kyle Lui,Principal, DCM Ventures
  • Jiong Ma,Partner, Braemar Energy Ventures
  • Jillian Manus,Founder, Structure Capital
  • Ezra Mehlman,Vice President, Health Enterprise Partners
  • Patricia Nakache,General Partner, Trinity Ventures
  • Ann Partlow,Co-founder/Partner, Earthrise Capital
  • Amit Patel,Principal, Master Owl Venture
  • Ketan Patel,Partner, Fidelity Biosciences
  • Alessandro Piol,Partner and Co-founder , AlphaPrime Ventures
  • Ulrich Quay,Managing Director, BMI i Ventures
  • Gopal Rajaraman ,Investment Analyst, Motorola Solutions Venture Capital
  • Tom Rand ,Managing Partner, Arctern Ventures
  • Bill Reinisch,Venture Partner, Paladin Capital
  • Aymerik Renard,Director, SanDisk Ventures
  • Evan Renov,Partner, Beechwood Ventures
  • Lisa Rhoads,Managing Director, Easton Capital
  • Steve Sarracino,Founder, Activant Capital Group
  • Claus Schmidt,Managing Director, Robert Bosch Venture Capital
  • Andrew Schoen,Associate, New Enterprise Associates
  • Reese Schroeder,Managing Director, Motorola Solutions Venture Capital
  • Tom Segal,Associate, Rethink Education
  • Stacey Seltzer,Partner, Aisling Capital
  • Clara Sieg,Partner, Revolution Ventures
  • Jeremy Sohn,Venture Partner, MPM Capital
  • Blake Stevens,Senior Associate, Harris & Harris Group
  • Alicia Syrett,Founder & CEO, Pantegrion Capital LLC
  • Bruce Taragin,General Partner, Blumberg Capital
  • Sebastian Titz,Managing Partner, 3M New Ventures
  • Alana Tung,Associate, Time Warner Investments
  • Claude Vachet,Managing Partner, Cycle Capital Management
  • Nic Wetzler,Associate, Augment Ventures
  • Lisa Wu,Vice President, Norwest Venture Partners
  • Greg Zaic,General Partner, Nexus Medical & Technology Capital
  • Tianxiang Zhuo,Managing Partner, Karlin Ventures
  • Alex Zisson,Partner, Thomas, McNerney & Partners
  • Chris Zock,Vice President, Sandbox Industries
  • Seth Zuckerman,Senior Associate, Safeguard Scientifics

 

FreeMind has made special arrangement for our network to receive a special discount of 10% off the existing “Early Bird” rates.

To Register now and receive the special discount as well as take advantage of the “Early bird” discount rate, use the link below and enter discount code “FREEMINDVIP”: http://bit.ly/1Q2RJlc
In addition to providing access to leading Investors, the conference will feature more than 50 pre-screened early stage companies seeking capital, and hardcore networking.

This conference will be attended by the best people in the industry. Please register early to avoid disappointment.

 

Call for TOP INNOVATORS!

Get Noticed > Get Funded > Grow Faster

A select group of more than 50 Top Innovators from the Technology, Life Sciences/Healthcare, CleanTech and Edtech sectors will be chosen to present their breakthrough investment opportunities to an exclusive audience of Venture Capitalists, Private Investors, Investment Bankers, Corporate Investors, and Strategic Partners.

Apply to Present / Nominate a company:

For more information or to be considered for one of the Top Innovator slots click here.

Seed Pitchfest:

If you are a seed stage company seeking angel funding of less than $1M (and have raised less than $300,000) click here to apply for our Seed stage track sponsored by the National Science Foundation.

 
REGISTER NOW and Save!!

 

FEES: “Early bird” registration Savings Available for a limited time!  Use Promotional code “FREEMINDVIP” and receive an extra 10% off.

Entrepreneurs: Regular: $395 | At the Door: $790

Investors: Regular: $495 | At the Door: $990)

Service Providers: Regular: $695 | At the Door: $1,390)

 

Special Thanks to our Sponsors & Industry Partners:

Goodwin Procter LLP, Sheppard Mullin, Pepper Hamilton LLP, National Science Foundation, Morgan Lewis, Mongotel, Motorola Solutions Venture Capital, Robert Bosch Venture Capital, Center for Israeli Innovation, Shufflrr, Arizona Bioindustry Association, National Venture Capital Association, FreeMind, Indiana Health Industry Forum, Angel Resource Institute,  Association of Cleantech Incubators of New England, Startup One Stop, Silicon Valley Startup Incubation and Acceleration, Business Innovation & Growth, GSAS Harvard Biotech Club, and Women’s Startup Lab..

 

FreeMind & youngStartup Ventures

 

To inquire about group rates, register by phone or for more information contact:

youngStartup Ventures at 212.202.1002

Venue: ETC Venues

Location: London, United Kingdom

Event Website

The 2nd annual Biotech and Money London 2016 event is a two-day congress providing the education, strategies and solutions you need to enable more effective funding, investment, business planning and partnering within your business.

HOW IT’S DIFFERENT

  • A qualified executive-level only audience
  • No CROs, CMOs or EQMs present
  • Innovative formats; no powerpoint
  • Content to match your investment lifecycle
  • Online showcases and company profiling
  • Qualified 1-2-1 partnering

WHO IS SPEAKING

Keynote speakers include:

  • Sir Chris Evans OBE, Chairman, Excalibur Group
  • Shaun Grady, Vice President, Business Development Operations, AstraZeneca
  • Luigi de la Corte, Head of WWBD, GlaxoSmithKline
  • Peter George, CEO, Clinigen
  • Darrin Disley, CEO, Horizon Discovery
  • Dan Mahony, Fund Manager, Polar Capital

8 REASONS TO ATTEND

  • Access capital. Find investors, funding sources and partners.
  • Leave with bold new ideas. No death by powerpoint.
  • Find the real sources of innovation. Meet the innovators, Inventors and entrepreneurs.
  • Real market insight: What’s driving UK bioscience? Find out here.
  • High calibre, qualified senior decision makers only. No EQMs, CROs or CMOs.
  • Brand new pharma and Medtech focus showcasing partnering opportunities.
  • Showcase your company. Slide deck on our exclusive online platform!
  • High powered networking, partnering and business development.

25% Discount Code: FMGLDN16

As Europe’s leading investment and biopartnering conference, BioTrinity is the nexus of a booming life sciences innovation ecosystem and provides a unique platform for R&D, global pharma and investor companies across the life sciences industry to achieve their business objectives; to secure funding, seek acquisition and in-licensing deals and grow their network.

BioTrinity is celebrating its 10 year anniversary in April 2016. To reflect the importance of this key industry event, the theme running through the programme is the ‘Vision for Life Sciences 2030’. The dedicated MediTrinity stream will also address the ‘Vision for Medtech 2030’.

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates.